ECCMID

21st27thECCMIDICCFinal ProgrammeEuropean Congress ofClinical Microbiology and Infectious DiseasesInternational Congressof ChemotherapyMilan, Italy7 10 May 2011 www.eccmid-icc2011.orgVisceral leishmaniasis:an endemic disease withglobal impactAn integrated symposium at the 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) and 27th International Congress of Chemotherapy (ICC), Milan, ItalyMonday 9 May 2011, 09.0011.00 Lecture Hall White 2 Co-ChairsO Lortholary (Paris, France)R N Davidson (London, United Kingdom) Prevalence, therapeutic need and effect of visceral leishmaniasis in developing countries J Alvar (Geneva, Switzerland) The latest evidence from large scale clinical trials S Sundar (Varanasi, India)Visceral leishmaniasis the European experience J-P Gangneux (Rennes, France)Organised and funded by Gilead Sciences Europe Ltd.Date of preparation: March 2011131/IHQ/11-01/NM/1042h 2011 Gilead SciencesLeishmania is not an approved indication for Liposomal Amphotericin B in ItalyTable of ContentsImportant Addresses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1Acknowledgements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3Welcome Address. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5Congress Venue Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6Committees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8Awards, Fellowships, Travel Grants . . . . . . . . . . . . . . . . . . . . . . 15Scientific Programme Overview . . . . . . . . . . . . . . . . . . . . . . . . . 32Introduction to the Scientific Programme. . . . . . . . . . . . . . . . 37Instructions for Authors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39ESCMID Study Group and other Business Meetings . . . . . . . . 40ISC Working Group and other Business Meetings . . . . . . . . . . 42Scientific ProgrammeSaturday,7 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43Sunday,8 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55Monday,9 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67Tuesday,10 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82Poster SessionsSaturday,7 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91Sunday,8 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107Monday,9 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141Tuesday,10 May 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175List of Chairpersons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193List of Authors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194Industrial Exhibition Overview . . . . . . . . . . . . . . . . . . . . . . . . . . 230List of Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233Exhibitors Guide. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237General Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267Social / Cultural Events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271Tours. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271Milan City Map. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276Future Congresses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278www.eccmid-icc2011.orgFinal Programme of the21st ECCMID / 27th ICC in Milan, Italy, 710 May 2011IntroductionImportant AddressesAddress during the Congress21st ECCMID / 27th ICCMilano Convention Centre MICViale Eginardo, 20149 Milan, ItalyPhone: +39 024 34 23 640, Fax: +39 024 34 23 642Congress PresidentProf Andrea NovelliUniversity of Florence, Department of Pharmacology Viale Pieraccini 6, 50139 Florence, ItalyPhone: +39 055 42 71 310, Fax: +39 055 42 71 280Email: [email protected] Secretariat21st ECCMID / 27th ICCc/o ESCMID Executive OfficeP.O. Box, 4002 Basel, SwitzerlandPhone: +41 61 686 77 99, Fax: +41 61 686 77 98Email: [email protected] Secretariat21st ECCMID / 27th ICCc/o Congrex Switzerland Ltd.P.O. Box, 4002 Basel, SwitzerlandPhone: +41 61 686 77 11, Fax: +41 61 686 77 88Email: [email protected] Congrex Travel Ltd.P.O. Box, 4002 Basel, SwitzerlandPhone: +41 61 690 94 11, Fax: +41 61 690 94 14Email: [email protected] BookingsCongrex Travel Ltd.P.O. Box, 4002 Basel, SwitzerlandPhone: +41 61 560 75 60, Fax: +41 61 690 92 14Email: [email protected] AgencyO.I.C. Srl Viale G. Matteotti 7, 50121 Florence, ItalyPhone: +39 055 50 351, Fax: +39 055 50 01 912Email: [email protected]:21st ECCMID / 27th ICCFinal ProgrammePublisher: 21st ECCMID / 27th ICCc/o Congrex Switzerland Ltd.P.O. Box4002 Basel, SwitzerlandPhone +41 61 686 77 11Fax +41 61 686 77 [email protected] / concept:Flux Design Studios www.fluxdesign.chLayout / print:Interrepro AGwww.interrepro.chSubject to programme changes without notice21st ECCMID / 27th ICC / Milan Final Programme 1Introduction MA l a i b o rro c i Me c n a v d A i t n e d I li t u l o S d e n o i t aat c n i s n o i We v i t aat v o n n I o m n r a e l o to t u o y e t i v n i e Wa t s e i g o l o n h c e t r p r u o t u o b a e rre ob r u o t aat s u t i s i vm t s e b o t d e r o l i a s t c u d o r1 2 1 . o n h t o o ba c i n i l c r u o y t e e m . s d e e n l a o b b a . w w w m o c . t t o Introduction AcknowledgementsThe Organising Committee expresses its thanks and appreciationto all who have generously contributed to the success of the21st European Congress of Clinical Microbiology and InfectiousDiseases and the 27th International Congress of Chemotherapy:Platinum Medal SponsorPfizerGold Medal SponsorAstellas Pharma EuropeSilver Medal SponsorsAbbottAstraZenecaBD DiagnosticsbioMrieuxBruker DaltonikCepheidGilead Sciences EuropeGlaxoSmithKline BiologicalsJanssenLuminex EuropeMSDNovartis PharmaSiemens HealthcareAdditional SponsorsBio-RadGen-ProbeOptimer PharmaceuticalsThe ECCMID-ICC Programme Committee is proud to acknowledge the scientific input from the following organisations in setting up joint workshops and symposia:API, Asociacin Panamamericana de Infectologa Infectious disease with liver involvement an update (page 83)ASM, the Interscience Conference on Antimicrobial Agents andChemotherapy (ICAAC)Antimicrobial peptides update for infectious disease physicians(page 48)EAPCRI, European Aspergillus PCR Initiative Educational Workshop 17: Just when you thought it was safe togo back in the water: leisure-associated water-borne infections(page 46)ECMM, European Confederation of Medical MycologyEducational Workshop 2: Fungi in the respiratory tract & antifungal stewardship (page 43)ESICM, European Society of Intensive Care MedicineHow to decrease resistance in the ICU (page 48)ERS, European Respiratory SocietyGRACE Educational Workshop 2: Fungi in the respiratory tract &antifungal stewardship (page 43)IDSA, Infectious Disease Society of AmericaClinical Grand Rounds (page 83)ISF, International Sepsis ForumISF Symposium and Presentation of International Sepsis ForumAward (page 51)ISHAM, International Society for Human and Animal Mycology Educational Workshop 17: Just when you thought it was safe togo back in the water: leisure-associated water-borne infections(page 46)21st ECCMID / 27th ICC / Milan Final Programme 3IntroductionAnswers for life.Only Siemens has the innovative solutions your lab needs to reach the top and the vision to keep you there.Planning for your future starts with choosing the right diagnostics partner today. Siemens provides comprehensive andcustomizable solutions so laboratorians and clinicians can improve productivity every day. And, with a 130-year tradition of innovation, you can trust Siemens to stay on the leading edge of emerging trends and technologies, so together wecan set a new standard in patient care for years to come. www.siemens.com/diagnosticsWho can really help me grow?A91DX-9105-A1-4A00 2010 Siemens Healthcare Diagnostics Inc. All rights reserved.Welcome AddressDear Colleagues and Friends,ItisagreatpleasureandprivilegetowelcomeyoutoMilan,Italy,onbehalfofESCMIDandISCandtothe 21st ECCMID / 27th ICC, the second joint meeting of both organising societies. As the result of what seems like aRenaissance mathematical cabala, both ESCMID and ISC held their 12th congresses in Italy, ESCMID 9 years agoin spring 2002 in Milan and the ISC 30 years ago in summer 1981 in Florence. For the second time we experiencea joint ECCMID/ICC congress. In these years ECCMID has steadily grown in importance while ICC has become aclassic worldwide biennial meeting for antimicrobial chemotherapy since 1961.We are pleased to offer you an excellent scientific programme, running over four days, with stimulating keynotelectures and symposia on parallel tracks with the involvement of a high number of internationally-renownedexperts. The programme provides an unique opportunity for debate, discussion and the exchange of importantideas and information in the fields of clinical microbiology, antimicrobial chemotherapy and infectious diseases.In addition, your contributions were highly welcomed and are presented in oral sessions or poster exhibitionsthatundoubtedlyincreasetheknowledgeofthelatestscientificdevelopmentsinthesefields.Manygreatscientists and experts from all over the world are taking part in this important joint meeting, where both clinicaland experimental research are showcased.The Milano Convention Centre (MIC), located right in the centre of town, has been recently completely renewed andis an even more attractive venue to meet old friends and to establish new and interesting contacts. The warmhospitality of this northern Italian city undoubtedly enhances the enjoyment of your stay. Milan is a sprawlingmetropolis, but most of its attractions are concentrated in the city centre, between the Duomo (cathedral) and theCastello Sforzesco. Milan is renowned throughout the world for its fine arts, grand music and, of course, it is oneof the most important fashion capitals. Immediately north of the Duomo, you may find not only the Brera ArtGalleries but also fashionable shopping avenues where you can sample all the different aspects of this importantEuropean city.We hope that this second joint meeting becomes a reference model for the exchange of scientific information inthe future. We wish you a fruitful meeting and a pleasant stay in Milan!Andrea Novelli21st ECCMID / 27th ICC PresidentTeresita MazzeiISC PresidentGiuseppe CornagliaESCMID PresidentJordi VilaECCMID / ICC Programme Director21st ECCMID / 27th ICC / Milan Final Programme 5IntroductionCongress Venue Overview6 21st ECCMID / 27th ICC / Milan Final ProgrammeIntroductionCongress Venue Overview21st ECCMID / 27th ICC / Milan Final Programme 7IntroductionLecture HallsMeeting RoomsExhibitionVarious Service Areas CommitteesOrganising CommitteeGiuseppe Cornaglia (Verona, IT), ESCMID PresidentFiona M. MacKenzie (Aberdeen, UK), ISC Executive DirectorTeresita Mazzei (Florence, IT), ISC PresidentAndrea Novelli (Florence, IT), 21st ECCMID / 27th ICC PresidentJordi Vila (Barcelona, ES), ECCMID/ICC Programme DirectorESCMID Executive CommitteeGiuseppe Cornaglia (Verona, IT) ESCMID PresidentMurat Akova (Ankara, TR)ESCMID Education OfficerGunnar Kahlmeter (Vxj, SE)ESCMID President-elect and Secretary GeneralWinfried V. Kern (Freiburg, DE)ESCMID TreasurerElisabeth Nagy (Szeged, HU)ESCMID Professional Affairs Officer Clinical MicrobiologyRobert C. Read (Sheffield, UK)ESCMID Scientific Affairs OfficerEvelina Tacconelli (Rome, IT)ESCMID Professional Affairs Officer Infectious DiseaseJordi Vila (Barcelona, ES)ECCMID/ICC Programme DirectorESCMIDAd hoc Executive Committee MembersAndrea Novelli (Florence, IT)21st ECCMID / 27th ICC PresidentJonathan Cohen (Brighton, UK) 22nd ECCMID PresidentDidier Raoult (Marseille, FR) CMI Editor-in-Chief8 21st ECCMID / 27th ICC / Milan Final ProgrammeISC Executive CommitteeTeresita Mazzei (Florence, IT)ISC PresidentAlasdair M. Geddes (Solihull, UK) IJAA Editor-in-ChiefIan M. Gould (Aberdeen, UK) Secretary GeneralAndy Hoepelman (Utrecht, NL)Po-Ren Hsueh (Taipei, TW) TreasurerShigeru Kohno (Nagasaki, JP) Vice-PresidentAndre Lomar (Sao Paulo, BR)Fiona M. MacKenzie (Aberdeen, UK) ISC Executive DirectorTetsuro Matsumoto (Kitakyoushu, JP) ISC Executive DirectorEnrico Mini (Florence, IT)Chair Cancer SectionKurt G. Naber (Straubing, DE) Immediate Past PresidentAndrea Novelli (Florence, IT) 21st ECCMID / 27th ICC PresidentDavid Paterson (Brisbane, AU)Malik Peiris (Hong Kong, HK)Chair Virology SectionCommittees21st ECCMID / 27th ICC / Milan Final Programme 9IntroductionAs the world leader in in-vitro diagnostics, Roche oers a broad portfolio of instruments and assays for the screening, diagnosis, and prevention of infectious diseases.Roche. Delivering on the promise of medical valueby enabling better patient treatment decisionsFor more information,see us at Booth #125ROCHE is a trademark of Roche. 2011 Roche Molecular Systems, Inc. All rights reserved. CommitteesRaul Raz (Afula, IL)Raphael Saginur (Ottawa, CA)Francesco Scaglione (Milan, IT)Wing-Hong Seto (Hong Kong, HK)Pramod Shah (Frankfurt, DE)Fred C. Tenover (Sunnyvale, US)ECCMID-ICC Programme CommitteeJordi Vila (Barcelona, ES), ECCMID/ICC Programme DirectorMurat Akova (Ankara, TR)Fausto Baldanti (Pavia, IT)Peter Chiodini (London, UK)Giuseppe Cornaglia (Verona, IT)Silvano Esposito (Naples, IT)Javier Garau (Barcelona, ES)Marek Gniadkowski (Warsaw, PL)Ian M. Gould (Aberdeen, UK)Gilbert Greub (Lausanne, CH)Stephan Harbarth (Geneva, CH)Andy Hoepelman (Utrecht, NL)Po-Ren Hsueh (Taipei, TW)Gunnar Kahlmeter (Vaxjo, SE)Winfried V. Kern (Freiburg, DE)Marc Lecuit (Paris, FR)Andre Lomar (Sao Paulo, BR)Fiona M. MacKenzie (Aberdeen, UK)Teresita Mazzei (Florence, IT)Patricia Muoz (Madrid, ES)Elisabeth Nagy (Szeged, HU)Andrea Novelli (Florence, IT)Eskild Petersen (Aarhus, DK)Mario Poljak (Ljubljana, SI)Didier Raoult (Marseille, FR)Robert C. Read (Sheffield, UK)Wing-Hong Seto (Hong Kong, HK)Stefania Stefani (Catania, IT)Evelina Tacconelli (Rome, IT)Fred C. Tenover (Sunnyvale, US)Johan Van Eldere (Leuven, BE)Claudio Viscoli (Genoa, IT)Katsunori Yanagihara (Nagasaki, JP)ESCMID Education SubcommitteeMurat Akova (Ankara, TR), ChairRoberto Cauda (Rome, IT)Peter Chiodini (London, UK)Jorge Garbino (Geneva, CH)Souha Kanj (Beirut, LB)Cornelia Lass-Flrl (Innsbruck, AT)Patrice Nordmann (Paris, FR)Tibor Pal (Al Ain, AE)Mical Paul (Petah Tikva, IL)Anna Skiada (Athens, GR)21st ECCMID / 27th ICC / Milan Final Programme 11IntroductionESCMID Scientific Affairs SubcommitteeRobert C. Read (Sheffield, UK), ChairMaiken C. Arendrup (Copenhagen, DK)Yehuda Carmeli (Tel Aviv, IL)Birgitta Evengrd (Ume, SE)Jan A.J.W. Kluytmans (Breda, NL)Hakan Leblebicioglu (Samsun, TR)Marc Lecuit (Paris, FR)Jesus Rodriguez-Bao (Seville, ES)Paul Savelkoul (Amsterdam, NL)Harald Seifert (Cologne, DE)Stefania Stefani (Catania, IT)ESCMID Professional Affairs SubcommitteeElisabeth Nagy (Szeged, HU), Chair, CM Evelina Tacconelli (Rome, IT), Chair, ID Bridget Atkins (Oxford, UK) Arta Olga Balode (Riga, LV) Nick J. Beeching (Liverpool, UK) Nur Benzonana (Istanbul, TR) Emmanuelle Cambau (Paris, FR) Giulia De Angelis (Rome, IT) John Edward Degener (Smalle, NL) Matthew E. Falagas (Athens, GR) Hilary Humphreys (Dublin, IE) Piotr Kochan (Cracow, PL) Laetitia M. Kortbeek (Bilthoven, NL)Truls Michael Leegaard (Lrenskog, NO) Endre Ludwig (Budapest, HU) Mario Umberto Mondelli (Pavia, IT) Patricia Muoz (Madrid, ES) Nicola Petrosillo (Rome, IT) Mario Poljak (Ljubljana, SI) Arjana Tambic Andrasevic (Zagreb, HR) Andrej Trampuz (Lausanne, CH) Andrew J. Ullmann (Mainz, DE) Nathalie Van Burgel (Leiden, NL) Jos Willem Maarten Van Der Meer (Nijmegen, NL) Alkiviadis C. Vatopoulos (Athens, GR) ESCMID Publication SubcommitteeGiuseppe Cornaglia (Verona, IT), ChairDidier Raoult (Marseille, FR)Verity Emmans (Oxford, UK)ESCMID Awards SubcommitteeGiuseppe Cornaglia (Verona, IT), ChairYehuda Carmeli (Tel Aviv, IL)Robert C. Read (Sheffield, UK)Stefania Stefani (Catania, IT)Parity CommissionElisabeth Nagy (Szeged, HU), ChairEvelina Tacconelli (Rome, IT), ChairNur Benzonana (Istanbul, TR)Laetitia M. Kortbeek (Bilthoven, NL)Mario Poljak (Ljubljana, SI)ISC Hamao Umezawa Memorial Award Advisory Board and CommitteeT. Mazzei (Florence, IT)W. Craig (Madison, US)A. Geddes (Solihull, UK)I.M. Gould (Aberdeen, UK)C. Kunin (Columbus, US)A. Nomoto (Osaka, JP)S. Omura (Tokyo, JP)A. Ronald (Manitoba, CA)ISC Executive CommitteeISC Tom Bergan Memorial Award CommitteeT. Mazzei (Florence, IT)I.M. Gould (Aberdeen, UK)P.R. Hsueh (Taipei, TW)F.M. MacKenzie (Aberdeen, UK)A. Novelli (Florence, IT)ISC John David Williams Memorial Award CommitteeT. Mazzei (Florence, IT)I.M. Gould (Aberdeen, UK)P.R. Hsueh (Taipei, TW)F.M. MacKenzie (Aberdeen, UK)T. Matsumoto (Kitakyoushu, JP)ISC Masaaki Ohkashi Award CommitteeT. Mazzei (Florence, IT)Members of the ISC UTI CommissionISC Young Investigator Travel Awards CommitteeT. Mazzei (Florence, IT)I.M. Gould (Aberdeen, UK)P.R. Hsueh (Taipei, TW)A. Novelli (Florence, IT)ISC / Inter American Society of Chemotherapy (IASC)Awards CommitteeT. Mazzei (Florence, IT)R. Feld (Toronto, CA)I.M. Gould (Aberdeen, UK)R. Sidwell (Logan, US)ISC Publication / Communication Committee: IJAAT. Mazzei (Florence, IT)A. Geddes (Solihull, UK)I.M. Gould (Aberdeen, UK)F.M. MacKenzie (Aberdeen, UK)12 21st ECCMID / 27th ICC / Milan Final ProgrammeESCMID Study GroupsAnaerobic Infections (ESGAI)www.escmid.org/esgaiElisabeth Nagy (Szeged, HU)[email protected] Policies (ESGAP)www.escmid.org/esgapDilip Nathwani (Dundee, UK)[email protected] Resistance Surveillance (ESGARS)www.escmid.org/esgarsGiuseppe Cornaglia (Verona, IT)[email protected] (ESGB)www.escmid.org/esgbNiels Hiby (Copenhagen, DK)[email protected] Parasitology (ESGCP)www.escmid.org/esgcpBirgitta Evengrd (Ume, SE)[email protected] difficile (ESGCD)www.escmid.org/esgcdEd J. Kuijper (Leiden, NL)[email protected], Anaplasma, Rickettsia and Bartonella (ESCAR)www.escmid.org/escarAchilleas Gikas (Heraklion, GR)[email protected] Markers (ESGEM)www.escmid.org/esgemSara Haeggman (Solna, SE)[email protected] and Water-borne Infections (EFWISG)www.escmid.org/efwisgKevin Kerr (Harrogate, UK)[email protected] Infection (EFISG)www.escmid.org/efisgManuel Cuenca-Estrella (Madrid, ES)[email protected] (EHSG)www.escmid.org/ehsgColm OMorain (Dublin, IE)[email protected] Infections (ESGIAI)www.escmid.org/esgiaiAndrej Trampuz (Lausanne, CH)[email protected] in Compromised Hosts (ESGICH)www.escmid.org/esgichClaudio Viscoli (Genoa, IT)[email protected] Borreliosis (ESGBOR)www.escmid.org/esgborGerold Stanek (Vienna, AT)[email protected] (EMESG)www.escmid.org/emesgStephen Leib (Berne, CH)[email protected] Diagnostics (ESGMD)www.escmid.org/esgmdPaul Savelkoul (Amsterdam, NL)[email protected] Infections (ESGMYC)www.escmid.org/esgmycEmmanuelle Cambau (Paris, FR)[email protected] Infections (ESGNI)www.escmid.org/esgniBarry D. Cookson (London, UK)[email protected]/PD of Anti-Infectives (EPASG)www.escmid.org/epasgUrsula Theuretzbacher (Vienna, AT)[email protected] Hepatitis (ESGVH)www.escmid.org/esgvhDominique Salmon-Ceron (Paris, FR)[email protected] ECCMID / 27th ICC / Milan Final Programme 13Introduction14 21st ECCMID / 27th ICC / Milan Final ProgrammeCommitteesISC Sections and Working GroupsCancer Sectionwww.ischemo.org/02_Section_CancerEnrico Mini (Florence, IT)[email protected] Sectionwww.ischemo.org/02_Sections_VirologyMalik Peiris (Hong Kong, HK)[email protected] of the Futurewww.ischemo.org/02_WG_AntimicrobialsFuturePaul M. Tulkens (Brussels, BE)[email protected] Antimicrobial Stewardshipwww.ischemo.org/02_WG_MRSA_AntimicrobialStewardshipJim Hutchinson (New Foundland, CA); Gabriel Levy Hara (Buenos Aires, AG)[email protected] Kramer (Greifswald, DE)[email protected], Skin and Soft Tissue Infections (SSTIs)www.ischemo.org/02_WG_BonesSkinSilvano Esposito (Naples, IT)[email protected] Effects of Anti-infectiveswww.ischemo.org/02_WG_CollateralEfectsAnti-InfectivesMihai Nechifor (Lasi, RO)[email protected] Aquired Pneumonia (CAP)Shigeru Kohno (Nahasaki, JP)[email protected] Antimicrobial Resistancewww.ischemo.org/02_WG_CARWing-Hong Seto (Hong Kong, HK)[email protected] Related Infections and Biofilmwww.ischemo.org/02_WG_BRIShigeru Kamiya (Tokyo, JP)[email protected] and Bloodstream Infections (BSI)www.ischemo.org/02_WG_EndocarditisEvangelos J. Giamarellos-Bourboulis (Athens, GR)[email protected] Infectionswww.ischemo.org/02_WG_FungalInfectionsJorge Garbino (Geneva, CH)[email protected] Interface in Antimicrobial Resistance (HAIR)www.ischemo.org/02_WG_HAIRErika Vlieghe (Antwerp, BE)[email protected] in Catastrophic Areaswww.ischemo.org/02_WG_ICAVladimir Krcmery (Bratislava, SK)[email protected] in the ICU www.ischemo.org/02_WG_ICUJean Carlet (Paris, FR)[email protected]/02_WG_MRSAHenri A. Verbrugh (Rotterdam, NL)[email protected] / Pharmacodynamicswww.ischemo.org/02_WG_PharmacokineticsFrancesco Scaglione (Milan, IT)[email protected] Infectionswww.ischemo.org/02_WG_StreptococcalPo-Ren Hsueh (Taipei, TW)[email protected] Tract Infectionswww.ischemo.org/02_WG_UrinaryKurt G. Naber (Straubing, DE)[email protected]/02_WG_ZoonosesGeorgios Pappas (Ioannina, GR)[email protected] ECCMID / 27th ICC / Milan Final Programme 15AwardsFinal Programme 2 Final ProgrammeE M Awards, Grants and Fellowships 2011ESCMID Award for Excellencein Clinical Microbiologyand Infectious DiseasesRino Rappuoli Born 1952 in Siena, Italy; Global Head Vaccines Research, Novartis Vaccines & Diagnostics, Siena, Italy. In the past decade Rino Rappuoli has become one of themajorexpertsinvaccinesandvaccinologyunani-mouslyrecognisedworldwide.Thankstohiscontribu-tions and original thinking, he has changed the way vac-cinesaremadeandthewaytheyareconceivedinthe research arena, and he had a great impact on the public healthperspective.Hiscontributionsintheeldofvac-cinologyencompassbroadareas.Hecharacterisedthe non-toxicmutantofdiphtheriatoxin(referredtoas CRM197)thatisnowutilisedasacarriermoleculefor manyefcaciousconjugatevaccines,suchasthose againstpneumococci,Haemophilus,meningococci,etc. Hisoriginalworkpavedthewaytothegeneticdetoxi-cation of bacterial toxins which led to the development of a novel vaccine against pertussis and to development of afamilyofstrongmucosaladjuvantsbasedonEs-cherichiacoliheat-labileenterotoxin.Herstconceived and applied the notion of reverse vaccinology, based on the systematic mining of microbial genomes. This novel experimentalapproachhasallowedthedevelopmentof a vaccine against group B meningococci which is show-ing now its efcacy in clinical studies in very young chil-dren.Thisnewmethodologyisnowbeingsuccessfully applied to the development of vaccines to other bacteria, suchasgroupAandBstreptococci,pneumococci,etc. Last but not least, his work on the development of novel adjuvant allowed the registration of the rst oil-in-water adjuvant(MF59)forhumanusewithaninuenzavac-cine.Thisworkrepresentedthebasisforthedevelop-mentofefcaciousvaccinesagainstpandemicinuen-za, both of avian and of swine origin.Inadditiontohisactiveinvolvementintheprivatesec-tor,hehasalwaysbeenactivelyinvolvedinaspectsre-latedtodevelopmentofvaccinesfordevelopingcoun-tries.ForseveralyearsRinoRappuoliservedinand chairedvariouscommittees,includingtheGlobalAlli-ance for Vaccines and Immunization (GAVI), dealing with vaccine development. More recently, he was instrumen-tal in the creation in 2008 of the Novartis Vaccines Insti-tutesforGlobalHealth(NVGH),whosemissionisthe development of vaccines against neglected diseases.RinoRappuoliistheauthor/co-authorofmorethan 500 scientic publications, the majority in peer-reviewed journals.Hehaseditedmorethantwelvebooksinvari-ous elds of vaccinology.The excellence of his work has been recognised by a long series of international awards, such as the Paul Ehr-lich and Ludwig Darmstaedter Prize in 1991, the Europe-an Federation of the Pharmaceutical Industries Associa-tionAwardin1992,theArimaAwardforAppliedMicro- biologyin2002,theGoldMedalAwardbythePresident oftheItalianRepublicin2005,theMiamiNatureBio-technologyWinterSymposiumSpecialAchievement Awardin2007,theAlbertB.SabinGoldMedalAwardin 2007, among others. In addition, in 2005 he was elected as a full member to the National Academy of Sciences of the USA.RinoRappuoliwillbepresentedtheESCMIDExcel-lenceAwardbyGiuseppeCornaglia,ESCMIDPresident and Chairman of the Awards Subcommittee, on Sunday, 8 May 2011. During the ceremony he will give his award lecture: Vaccines, medicine and public health in the XXI century.ECCMID-ICC 2011 Experience BD Diagnostics from lab efciency to clinical responsivenessExperience innovative technologies, premium education and passionate people.Visit BD Diagnostics.Please join us forcoffee and pastriesoutside the lecture hall as of 08:30. ///Streamlining the microbiology lab for improveddiagnostic utility Prof. A. Simon, UCL ST Luc Brussels, Belgium///Saving time in sepsis diagnostics MALDI-TOF MSfor identication of bacteria and yeasts frompositive blood cultures Prof. S. Schubert, Ludwig-Maximilians-Universitt (LMU) Munich, Germany///Monitoring of bone and joint samples with lastgeneration automated blood culture systems:faster and betterDr. M. Rottman and Dr. A. Dinh, Hpital Raymond-Poincar, Paris, France///New emerging resistances: challenges andimplications for efcient diagnosis and effectivetreatment in critical patientsProf. G.M. Rossolini, Azienda Ospedaliera Universitaria Senese, Siena, Italy;Dr. G. Tulli, Nuevo Ospedale San Giovanni di Dio, Florence, ItalyMonday, 9th May Lecture Hall: Amber 1 09.00 11:00 INTEGRATED SYMPOSIUMThe efcient laboratory an ideal partner in clinical practice

Prof. J. van Eldere, Leuven, Belgium Prof. G.M. Rossolini, Siena, ItalyChair: an ideal partner in clinical practiceThe efcient laboratory

Prof. J. van Eldere, Leuven, Belgium Prof. G.M. Rossolini, Siena, Italy an ideal partner in clinical practiceThe efcient laboratory

Prof. J. van Eldere, Leuven, Belgium Prof. G.M. Rossolini, Siena, Italy an ideal partner in clinical practiceThe efcient laboratory

an ideal partner in clinical practice

Prof. J. van Eldere, Leuven, Belgium

as of 08:30. outside the lecturfee and pastriescofPlease join us for

as of 08:30. e halloutside the lecturfee and pastries Please join us for

Awards21st ECCMID / 27th ICC / Milan Final Programme 17 Final Programme 2 Final ProgrammeESCMID Young Investigator Awards for Research in ClinicalMicrobiology and Infectious DiseasesSurbhi Malhotra-Kumar Born 1972 in Sirsa, India; PhD, Senior Research Fellow at the Laboratory of Medical Microbiology, Vaccine and In-fectiousDiseaseInstitute,UniversityofAntwerp,Bel-gium, in recognition of her outstanding achievements in bridgingthegapbetweenbasicandecologicresearch and in trying to link antibiotic use to the emergence and persistence of antibiotic resistance.SurbhiMalhotra-Kumarwillbepresentedheraward duringtheESCMIDYoungInvestigatorAwardsSession onTuesday,10May2011.Duringthesession,shewill give a talk on Changing perspectives on antibiotic ther-apy:fromprovingtheobvioustoexploringinnovative strategies.Research InterestsSurbhi Malhotra-Kumar completed her Masters in Medi-calMicrobiologyin1998,MastersinMolecularBiology in 2003; and a PhD in Medical Microbiology in 2005 un-derthesupervisionofHermanGoossens.Theresearch of Surbhi Malhotra-Kumar has focused on the molecular epidemiologyandgeneticsofresistancetocommon groupsofantimicrobialsinoralstreptococci.Applying molecularbiologicaltechniquesonoro-pharyngeal streptococcalorainhealthyindividualsasamodel, she demonstrated that antibiotic use is the single most importantdriverofantibiotic-resistanceinvivo,that antibiotics belonging to the same class can differ wide-lyinresistancegeneselection,andthatdifferencesin predominance of certain resistance genes in geograph-icallydistinctareasmightbelinkedtothepreferential useofspecicantibioticsubclasses.Hercurrentre-searchinterestsincludestudyingtheimpactofantibi-oticuseonthenaso-oro-pharyngealandintestinal microbiome,mechanismsofbiolmformation,animal models of infection, and developing rapid diagnostic as-saysforpathogenscausingcommunity-acquiredand nosocomial infections.Annelies Zinkernagel Born 1972 in Basel, Switzerland, Attending Senior Physi-cian, Division of Infectious Diseases and Hospital Epide-miology, University Hospital Zurich, Switzerland, in rec-ognitionofherimpactonourunderstandingofcritical aspectsoftheinteractionbetweenstreptococciand staphylococci and the host innate immune system.AnneliesZinkernagelwillbepresentedheraward duringtheESCMIDYoungInvestigatorAwardsSession onTuesday,10May2011.Duringthesession,shewill giveatalktitledKnowyourenemyGroupAstrepto-coccal virulence factors.Research InterestsAnneliesZinkernagelcompletedhertraininginInternal Medicine(2002)andInfectiousDiseasesin2005at theUniversityHospitalofZurich,Switzerland,followed byaPhDin2009andpostdoctoralfellowshipinthe laboratoryofVictorNizetinSanDiego,California,USA. ThereshestudiedgroupAstreptococcalvirulencefac-torsandhowtheseallowthebacteriatoevadethe hostsinnateimmunesystem.Currentlyshecombines her clinical and laboratory expertise and works as an at-tendinginfectiousdiseasespecialistattheUniversity Hospital of Zurich, Switzerland, where she also leads an independent research group. Her translational research focusesonunderstandingbacterialvirulencefactors and corresponding innate immune response pathways. Improved knowledge on host pathogen interaction may allow to develop novel treatment options that can either neutralizethebacterialvirulencefactorsorboostthe hostdefenseandimproveoutcomeinpatientssuffer-ing from infectious diseases.The Young Investigator Awards are sponsored by Pzer.A

i a GLAXOSMITHKLINE INTEGRATED SYMPOSIUM 21ST EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID) &27TH INTERNATIONAL CONGRESS OF CHEMOTHERAPY (ICC) Milan, Italy Bacterial invasive and non-invasive diseases: aetiology, epidemiology, treatment implications, prevention and surveillanceSaturday7thMay2011 16. 30-18. 30 Mi l anCongressCent re, Lect ureHal l Amber 416.30Welcome and introductionProf. Andrea Novelli(Italy)Are dual infections myth or reality? The example of otitis mediaProf. Ron Dagan (Israel) Evolving resistance in respiratory pathogens and its implicationsProf.Johan Van Eldere (Belgium) Potential benet of integrating vaccination in clinical guidelines to optimize antibiotic use Prof. Paola Marchisio (Italy) The need for improved surveillance of invasive bacterial diseaseDr Mary Slack (United Kingdom) Question and answer session All faculty18.30 Symposium closeChairProf. Andrea Novelli University of Florence, Italy Co-chairProf. Johan Van Eldere UZ Leuven, Laboratory Medicine, Leuven, BelgiumGraphic Design: visible.be (7303) BIO/SYN/0013/11 Production March 2011, Wavre, Belgium

Awards21st ECCMID / 27th ICC / Milan Final Programme 19 Final Programme 4 Final ProgrammeESCMID Excellence TrainingAwardees 2011 V Axel Hamprecht, Cologne, GermanyDuringhismedicalstudieshedevelopedakeeninterestininfectious diseases and tropical medicine and did internships in Botswana and at the WHO in Geneva. He pursued medical training in France, Switzerland and the UK and later completed his MD thesis at the Institute for Medi-calMicrobiologyoftheCharit,Berlin.Afterhisclinicalterm,Axelbe-came a trainee in microbiology at the Institute for Medical Microbiology, Immunology and Hygiene of the University Hospital Cologne.Havingastronginterestinmycology,hereceivedfurthertrainingin this eld at the Pasteur Institute in Paris. He established an intense co-operationwithcolleaguesinthedepartmentofinfectiousdiseasesat CologneandmycologistsindifferentEuropeancountries,resultingin different mycological projects. He also works in the Clinic of Travel Medi-cineandinajointprojectwithahospitalinIvoryCoast.Heisveryin-volvedintheteachingofmedicalstudentsandgiveslecturesand courses in microbiology and mycology. Currently, he is in the nal year of his training in microbiology.Hilmir Asgeirsson, Huddinge, Sweden The recipient studied medicine at the Faculty of Medicine of the Univer-sity of Iceland from September 1999 to June 2005. After his intern year he worked three months as a volunteer in Ethiopia. From January 2007 to January 2010 he did his residency in internal medicine at Landspitali University Hospital, Reykjavik, Iceland. During this time he was involved inepidemiologicalresearchonS.aureusbacteraemiaresultinginpub-lishedarticlesandposterpresentationsatinternationalconferences. He has also published papers in other sub-specialities of internal medi-cineandhasbeeninvolvedinteachingclinicalskillstomedicalstu-dents. Since February 2010 he has continued his training in infectious diseas-es at the Department of Infectious Diseases of the Karolinska Universi-tyHospitalinSweden.Mostrecently,heparticipatedintheSwedish-EthiopianCourseinTropicalInfectiousDiseases2010-2011andhas become a member of a competence group on tropical infections at the KarolinskaUniversityHospital.Heisexpectedtonishhistrainingin December 2012.20 21st ECCMID / 27th ICC / Milan Final Programme Final Programme 4 Final ProgrammeE AValentina Mazzocato, Rome, ItalyShe started her studies at the La Sapienza University and from the be-ginning has carried out extracurricular activities focused on social med-icine:ShecollaboratedwithSISM(ItalianSecretariatMedicineStu-dents)andjoinedtheCaritas(CatholicCharity)voluntaryprogramme for medicine students working at Caritas Immigrant Ambulatory. For her thesiswork,shecarriedoutresearchontheImmigrantAmbulatoryat theUmbertoIHospital.In2004ValentinaMazzocatowasenrolledin theSISMResearchExchangeProgrammeinHospitalSaoRafael,Brazil as a trainee student to improve her medicine competence in a tropical environment. In 2010 she participated in an Observership in Ankara at theDepartmentofInfectiousDiseases,HacettepeUniversityandNu-mune State Education and Research Hospital. CurrentlysheisemployedasaresidentdoctoratGemelliHospitalin Rome, in the infectious diseases and ambulatory units, where she also participatesinprojectsandnetworkingactivitiesbetweenherdepart-mentdisciplinesandrelatedspecialtiesaswellasinstudentgroups andsocialcampaignsforSTDprevention.Herinterestsareonstudies aboutARVadherence,vaccinations,tuberculosisandclinicalultra-sound.Djin-Ye Oh, Berlin, GermanyShe is currently training in pediatrics at Tufts Medical Center in Boston, USA.ThistrainingisinadditiontoherMicrobiologytrainingatCharit University Medical Center in Berlin, Germany. Her multifaceted teaching approachintegratesbasicscience,laboratorymedicineandclinical medicine.Herresearchexperienceincludesstudiesonthemolecular epidemiologyofRNAviruses(RobertKoch-Institute,Germany),analy-sesontheimpactofinnateimmunesystemgeneticvariationonRNA viraldiseases(CharitUniversityMedicalCenter)andtheuseofadju-vantforpotentialneonatalvaccines(ChildrensHospitalBoston / Har-vard Medical School). She has initiated and coordinated several collabo-rations between basic science labs and clinical research groups.Her clinical training and research efforts have strengthened her convic-tion that academic research and clinical medicine should exist as mutu-ally supportive entities in the common service of promoting the human welfare. Therefore, she envisions an academic career that consistently integratesherscienticknowledgeandlaboratoryskillswithclinical experience.A Awards21st ECCMID / 27th ICC / Milan Final Programme 21Final Programme 6 Final ProgrammeFuad IraqiBorn on March 1st, 1961 in Tira City, Israel; Department of Clinical Micro-biology and Immunology, Sackler Faculty of Medicine, Tel-Aviv Universi-ty, Tel-Aviv, Israel, in recognition of his excellent abstract submitted for presentation at the 21st ECCMID / 27th ICC 2011.HewillgiveashortoralpresentationtitledThecollaborativecross mousegeneticreferencepopulationasnoveltoolfordissectinghost susceptibility to infectious diseases at the Sepsis Forum on Saturday, 7 May 2011. Research InterestsFuadIraqiisamoleculargeneticistwhohasworkedforthelastfour years at the Tel-Aviv University. His research is focused on understand-ing diseases' etiology and host susceptibility to infectious and chronic diseases including; Klebsiella pneumonia, Aspergillus fumigatus perio-dontitis, type-2 diabetes and modiers for colon cancer. In addition he is working on a project for identifying the host genetic factors inuenc-ing immune response cell lineages in peripheral blood in the naive pop-ulation,aimingtousingthisinformationinapredictivegeneticsap-proach.FollowinghisgraduationfromtheHebrewUniversityin Jerusalem in 1989, he worked for two years at the Hospital for Sick Chil-dreninToronto,Canada,twomoreyearsatMichiganStateUniversity, USA,beforeworkingforthirteenyearswithILRIinNairobi,Kenyaon mapping genes associated with host susceptibility to trypanosomiasis, gastrointestinal nematodes and malaria in target species and a mouse model.ISF Sepsis Award E

U U

o

a

C

a

C

o

S

O

O 22 21st ECCMID / 27th ICC / Milan Final Programme Final Programme 6 Final ProgrammeF ESCMID Research Grants 2011The following ESCMID members have received a Research Grant in 2011 for the indicated project.Helen Louisa Leavis Medical Microbiology,UMC Utrecht,Utrecht, The NetherlandsProject: Pathogenesis of Enterococcus faecium biolm formationAlain BizziniInstitute of Microbiology, University Hospital Center Lausanne, Lausanne, SwitzerlandProject: Study of the emergence and evolutionof antibiotic heteroresistance by microcalorimetry inan experimental model of foreign-body infectionDafne BongiornoDepartment of Microbiology, University of Catania,Catania, ItalyProject: Non-mutational resistance to linezolid: characterisation of the plasmid-mediated methyltransferase cfr geneAlessandra BragonziSan Raffaele Scientic Institute, Milano, ItalyProject: Tracking down virulence of Pseudo-monas aeruginosa during chronic infectionMatthijs Christian BrouwerDepartment of Neurology, Center of Infectionand Immunity Amsterdam, Academic MedicalCentre, University of Amsterdam, The NetherlandsProject: The plasminogen system in bacterial meningitisPaola Brun Department of Histology, Microbiology and Medical Biotechnologies, Universityof Padua, Padua, ItalyProject: Molecular mechanisms of neurotropic virus-mediated neuropathies in the gutPaolo MiottoEmerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, Fondazione CentroSan Raffaele del Monte Tabor, Milan, ItalyProject: The role of small RNAs in the stress response of Mycobacterium tuberculosisSergio Filipe Academic and Projects Ofce, Instituto de Tecnologia Quimica e Biologica,Oeiras, PortugalProject: Identication of bacterial cell wall components that interfere with peptidoglycan recognition by the hostMariana PinhoAcademic and Projects Ofce, Instituto de Tecnologia Quimica e Biologica,Oeiras, PortugalProject: Study of the real-time response of individual Staphylococcus aureus cells to the presence of cell wall active antibioticsFinal Programme 8 Final ProgrammeESCMID Research Grants 2011(cont.) ESCMID Training Fellowships 2011Andrew James StewardsonInfection Control Program, University of Geneva Hospitals,Geneva, SwitzerlandProject: The household micro-biome: a prospective obser-vational study investigating household clustering of oral and intestinal microbiota and the impact of oral antibiotic exposureN

U Andreas ReisnerBiomedical Science, University of Applied Sciences, Graz, AustriaProject: Prevalence and spread of bacterial silver resistanceV

o Pierre SmeestersBacterial Genetics and Physiology Laboratory,Free University of Brussels, Gosselies, BelgiumProject: Host-pathogen interactions in a highly necrotising group A Streptococcus isolateI

H G

S

NThamarai SchneidersCentre for Infection and Immunity, Queens University Belfast, Belfast, United KingdomProject: The frontline defense: sRNA-mediated mechanisms in antibiotic resistance Eveline SneldersMedical Microbiology, Radboud University Nijmegen Medical Center,Nijmegen, The NetherlandsProject: The tandem repeat as a resistance mechanism in human and plant pathogenic fungiRonald van RijMedical Microbiology, Radboud University Nijmegen Medical Centre,Nijmegen, The NetherlandsProject: A high-throughput screen to identifysmall molecule inhibitorsof Dengue virus

Roy SleatorBiological Sciences, Cork Institute of Technology,Cork, IrelandProject: Development of a novel immunoprophylaxis strategy for controlling Campylobacter jejuniRita SobralLaboratory of Molecular Genetics, Institutode Tecnologia Quimicae Biologica,Oeiras, PortugalProject: The association of extracellular DNA tothe Staphylococcus aureus surface: roles and mechanismsNicolas VezirisLaboratoire de bactriologie, UPMC, Paris, FranceProject: In vivo evaluation of the benet of adding moxioxacin to drug regimens used against extensively drug-resistant tuberculosis21st ECCMID / 27th ICC / Milan Final Programme 23Awards24 21st ECCMID / 27th ICC / Milan Final Programme Final Programme 8 Final ProgrammeE ESCMID Training Fellowships 2011A

G Neven PapicDepartment of Viral Hepatitis,University Hospital for Infectious Diseases, Zagreb, CroatiaProject: Discovery of host antiviral genes regulating hepatitis C replicationHost: Curt Hagedorn, Division of Gastro-enterology, Hepatology and Nutrition, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, USA Vincent CattoirDepartment of Microbiology, Hpital Cte de Nacre, Caen, FranceProject: Systems approach towards under-standing post-transcriptional regulationof expression of Pseudomonas aeruginosa genes important for pathogenesis Host: Stephen Lory, Harvard Medical School, Department of Microbiology and Molecular Genetics, Boston, USA

F Ioana Sabina MacoveiLaboratory of Anaerobic Bacteria, Cantacuzino Institute, Bucharest, RomaniaProject: Clostridium difcile and CDAD laboratory typing methods and molecular epidemiologyHost: Emilio Bouza, Department of Clinical Microbiology and Infectious Diseases,Hospital General UniversitarioGregorio Maran, University of Madrid, SpainMaria Chiara Di LucaLaboratory of Microbiology,School of Biosciences and Biotechnology, University of Camerino, Camerino, ItalyProject: Clinical and molecular microbiology of group A StreptococcusHost: James M. Musser, The Methodist Hospital Research Institute, Department of Pathology and Laboratory Medicine, Houston, USAJoseph MeletiadisLaboratory of Clinical Microbiology, Attikon University Hospital, Athens, GreeceProject: Experimental model for studying combination therapy against azole-resistant Aspergillus fumigatus isolatesHost: Paul E. Verweij, Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen Institute for Infection, Inammation and Immunity,Nijmegen, The Netherlands

N

N

s oCorine Geurts van KesselDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC Rotterdam, Rotterdam, The NetherlandsProject: A clinical fellowship in tropical infectious diseases in BangladeshHost: Hubert Ph. Endtz, Department of Tropical Bacteriology and Director Laboratory Sciences Division, ICDDR'B, Dhaka, BangladeshIoana Raluca MihailescuNational Institute of Infectious DiseasesProf. Dr. Matei Bals, Bucharest, RomaniaProject: Antimicrobial activity against vancomycin-resistant enterococci (VRE) biolms in experimental implant-associated infections Host: Andrej Trampuz, Department of Infectious Diseases, University Hospital Lausanne, Department of Infectious Diseases Septic Surgical Unit, Lausanne, Switzerland

C

d e Biologica,O

t Final Programme 1 Final ProgrammeISC Honorary MembershipISC Honorary Membership is conferred upon persons who have brought outstanding contributions to chemotherapy. The awardees in 2011,in conjunction with the 27th ICC, are:This is the highest award given by the ISC for outstandingcontributions in the eld of chemotherapy.Professor Fernando BaqueroFernandoBaqueroisResearchProfessor inBacterialEvolutionattheBiomedical ResearchFoundationandDepartmentof Microbiology of the Ramon y Cajal Univer-sity Hospital, Madrid.Hehasmademajorcontributionsto antimicrobialchemotherapyovermany years resulting (at the last count) in 360 scientic papers cited in PubMed.Hisresearchinterestsarewide-rang-ingandincludethebiochemistry,genet-ics,populationbiology,ecologyandevo-lutionofantimicrobialresistanceand bacterial virulence.Professor Javier GarauJavierGarauisAssociateProfessorof MedicineintheUniversityofBarcelona, SpainandHeadoftheDepartmentof Medicine the Mutua de Terrassa Hospital.Hehasmadeimportantcontributions to antimicrobial therapy, especially in the areaofrespiratorytractinfectionsin which he is a world authority.Professor Garau played a major part in thesuccessoftheEuropeanSocietyof ClinicalMicrobiologyandInfectiousDis-eases,particularlyinhisroleasEduca-tion Ofcer and President.Professor Helen GiamarellouHelenGiamarellouisadistinguished Greek infectious diseases physician who has made important contributions to an-timicrobialchemotherapybothinre-searchandinthetrainingofyoungphy-sicians and microbiologists.ShehasservedontheBoardsofna-tionalandinternationalsocietiesand alsotheEditorialBoardsseveralprestig-iousjournals.Herresearchinterestsare wide-rangingandincludelaboratory studiesonantibacterialagentsbothin vitro and in animal models, and also clini-caltrialsinhumans.Theyhaveresulted in the publication of over 1000 papers in scientic journals.

T

oThe Award is provided by the Microbial Chemistry Research Foundation of Japan in honour of the late Professor Umezawa.ISC Hamao Umezawa Memorial AwardProfessor Stuart B. Levy The2011awardeeisProfessorStuartB.LevywhoisProfessorofMo-lecularBiologyandMicrobiologyandofMedicineandDirectorofthe Centre for Adaptation Genetics and Drug Resistance at Tufts University School of Medicine. For about 40 years, Professor Levy has combined basic science re-searchwithpublichealthinitiativesandeducationaimedatunder-standingappropriateuseofantibioticsandcurbingantibioticresist-ance. A number of seminal ndings include his discovery of active drug efux as a mechanism for antibiotic (tetracycline) resistance; the dis-coveryofthechromosomalregulatorylocusformultipleantibioticre-sistance(marlocus)andvirulence;therstdemonstrationofthe transfer of resistance genes and resistant bacteria among animals and people;anddiscoveryofthemajortargetfortriclosan(acommonly-used biocide). His studies have inuenced efforts in infectious disease research and public health policy worldwide to increase public and pro-fessionalawarenessofantibioticresistanceandoftheproperuseof antibiotics. Hiswidely-cited1992/2002bookTheAntibioticParadox:HowMira-cle Drugs are Destroying the Miracle has been translated into many lan-guages. In1981,ProfessorLevyco-foundedtheAllianceforPrudentUseof Antibiotics(APUA)usingnetworks,country-widechapters(currently 65),andindividualstofosterprudentantibioticuseandstrategiesto curtail antibiotic resistance.The ISC Hamao Umezawa Memorial Award Lecture will be presented on Sunday, 8 May 2011at 14.30 in Lecture Hall White 3 and is titled: Antibiotic resistance: back to the bigger circlec f o d l e e h t n i s n o i t u b i r t n o cv i g d r a w a t s e h g i h e h t s i s i h Tz e m U o a m a H C S I

. y p a r e h t o m e h cg n i d n a t s t u o r o f C S I e h t y b n e vd r a w AAw l a i r o m e M a w a z

h t h t i w n o i t c n u j n o c n it u b i r t n o c g n i d n a t s t u or e b m e M y r a r o n o H C S Iy r a r o n o H C S I d

: e r a , C C I h t 7 2 e he d r a w a e h T . y p a r e h t o m e h c o t s n o i th w s n o s r e p n o p u d e r r e f n o c s i p i h s rp i h s r e b m e M y

, 1 1 0 2 n i s e et h g u o r b e v a h o h

c

:

.

a r e h t o m e h c l a i b o r c i m i t n ac r o j a m e d a m s a h e H. d i r d a M , l a t i p s o H y t i sn o m a R e h t f o y g o l o i b o r c i Md n a n o i t a d n u o F h c r a e s e Rt a n o i t u l o v E l a i r e t c a B n ie s e R s i o r e u q a B o d n a n r e Fu q a B o d n a n r e F r o s s e f o r P

y n a m r e v o y p ao t s n o i t u b i r t n o c- r e v i n U l a j a C y nf o t n e m t r a p e Dl a c i d e m o i B e h tr o s s e f o r P h c r a eo r e u

.

e

.

y

o e s u e t a i r p o r p p a g n i d n a t si h t l a e h c i l b u p h t i w h c r a e se f o r P , s r a e y 0 4 t u o b a r o F. e n i c i d e M f o l o o h c St e n e G n o i t a t p a d A r o f e r t n e Ci b o r c i M d n a y g o l o i B r a l u c e ls e f o r P s i e e d r a w a 1 1 0 2 e h Tyv e L . B t r a u t S r o s s e f o r P

t o i b i t n a g n i b r u c d n a s c i t o i b i t n a fa d e m i a n o i t a c u d e d n a s e v i t a i t i n ic s c i s a b d e n i b m o c s a h y v e L r o s s eU s t fft u T t a e c n a t s i s e R g u r D d n a s c it c e r i D d n a e n i c i d e M f o d n a y g o l os s e f o r P s i o h w y v e L . B t r a u t S r o s s

- t s i s e r c i- r e d n u t a- e r e c n e i cy t i s r e v i ne h t f o r o- o M f o r o

u a r a G r e i v a J r o s s e f o r P. e c n e l u r i v l a i r e t c a br l a i b o r c i m i t n a f o n o i t u lc e , y g o l o i b n o i t a l u p o p , s c ih c o i b e h t e d u l c n i d n a g n is t s e r e t n i h c r a e s e r s i HP n i d e t i c s r e p a p c i t n e i c ss a l e h t t a ( g n i t l u s e r s r a e y

d n a e c n a t s i s e r- o v e d n a y g o l o c- t e n e g , y r t s i m e- g n a r - e d i w e r a. d e M b u P0 6 3 n i ) t n u o c t sy y p

. s c i t o i b i t n at n a f o s s e n e r a w a l a n o i s s e fp h t l a e h c i l b u p d n a h c r a e s e rh s e i d u t s s i H . ) e d i c o i b d e s uh t f o y r e v o c s i d d n a ; e l p o e ps e n e g e c n a t s i s e r f o r e f s n a r td n a ) s u c o l r a m ( e c n a t s i sl a m o s o m o r h c e h t f o y r e v o ca r o f m s i n a h c e m a s a x u f e l a n i m e s f o r e b m u n A . e c n a

e p o r p e h t f o d n a e c n a t s i s e r c i t o i b ic i l b u p e s a e r c n i o t e d i w d l r o w y c i l o ps u o i t c e f n i n i s t r o f f e d e c n e u n i e v ao c a ( n a s o l c i r t r o f t e g r a t r o j a m e hm i n a g n o m a a i r e t c a b t n a t s i s e r d n a so i t a r t s n o m e d t s r e h t ; e c n e l u r i vi t n a e l p i t l u m r o f s u c o l y r o t a l u g e re c n a t s i s e r ) e n i l c y c a r t e t ( c i t o i b i t n ac a f o y r e v o c s i d s i h e d u l c n i s g n i d n

f o e s u r e- o r p d n ae s a e s i d s- y l n o m md n a s l a me h t f o n- e r c i t o i b- s i d e h t ; eg u r d e v i t c

p o r u E e h t f o s s e c c u s e h td e y a l p u a r a G r o s s e f o r Pr o h t u a d l r o w a s i e h h c i h wc a r t y r o t a r i p s e r f o a e r ae , y p a r e h t l a i b o r c i m i t n a o tn a t r o p m i e d a m s a h e Hr e T e d a u t u M e h t e n i c i d e Me h t f o d a e H d n a n i a p St i s r e v i n U e h t n i e n i c i d e Mt a i c o s s A s i u a r a G r e i v a J

f o y t e i c o S n a e pn i t r a p r o j a m a d. y t i rn i s n o i t c e f n i te h t n i y l l a i c e p s es n o i t u b i r t n o c t n. l a t i p s o H a s s a r rf o t n e m t r a p e D, a n o l e c r a B f o yf o r o s s e f o r P e t

y

y

h

d

U f Pu o F h c r a e s e Rs i d r a w A e h T. e c n a t s i s e r c i t o i b i t n a l i a t r u ct s o f o t s l a u d i v i d n i d n a , ) 5 6e n g n i s u ) A U P A ( s c i t o i b i t n Ay v e L r o s s e f o r P , 1 8 9 1 n I. s e g a u ge h t g n i y o r t s e D e r a s g u r D e l c0 2 / 2 9 9 1 d e t i c - y l e d i w s i H

e h t f o r u o n o h n i n a p a J f o n o i t a d n us i m e h C l a i b o r c i M e h t y b d e d i v o r p.a r t s d n a e s u c i t o i b i t n a t n e d u r p r ec ( s r e t p a h c e d i w - y r t n u o c , s k r o w t en e d u r P r o f e c n a i l l A e h t d e d n u o f - o cm o t n i d e t a l s n a r t n e e b s a h e l c a r i M eH : x o d a r a P c i t o i b i t n A e h T k o o b 2 0 0

et a l eyr to t s e i g e ty l t n e r r u cf o e s U t n- n a l y n a m- a r i M w o H

i i t h t i d hp a r e h t o m e h c l a i b o r c i m i tt n o c t n a t r o p m i e d a m s a hs e s a e s i d s u o i t c e f n i k e e r Ga s i u o l l e r a m a i G n e l e He r a m a i G n e l e H r o s s e f o r P. t n e d i s e r P d n a r e c f O n o i ts i h n i y l r a l u c i t r a p , s e s a ed n a y g o l o i b o r c i M l a c i n i l C

h f- e r n i h t o b y- n a o t s n o i t u b i ro h w n a i c i s y h p sd e h s i u g n i t s i du o l l e.- a c u d E s a e l o r- s i D s u o i t c e f n I

f

t

i

h

m U r o s s e ffe o r Ps e r c i t o i b i t n Ae L n i 0 3 . 4 1 t an e s e r p e b l l i wa m a H C S I e h T

. a w a z e me l c r i c r e g g i b e h t o t k c a b : e c n a t s i s: d e l t i t s i d n a 3 e t i h W l l a H e r u t c e1 1 0 2 y a M 8 , y a d n u S n o d e t nu t c e L d r a w A l a i r o m e M a w a z e m U o a

e r u

r e v o f o n o i t a c i l b u p e h t n iy e h T . s n a m u h n i s l a i r t l a cs l e d o m l a m i n a n i d n a o r t i vl a i r e t c a b i t n a n o s e i d u t su l c n i d n a g n i g n a r - e d i wc r a e s e r r e H . s l a n r u o j s u o is s d r a o B l a i r o t i d E e h t o s l al a n o i t a n r e t n i d n a l a n o i te h t n o d e v r e s s a h e h St s i g o l o i b o r c i m d n a s n a i c i sg n i n i a r t e h t n i d n a h c r a e s

n i s r e p a p 0 0 0 1d e t l u s e r e v a h y- i n i l c o s l a d n a , sn i h t o b s t n e g ay r o t a r o b a l e d ue r a s t s e r e t n i h c- g i t s e r p l a r e v e sd n a s e i t e i c o s- a n f o s d r a o B e. s t- y h p g n u o y f o g

f

o

.

d

.

M

e

. s l a n r u o j c i t n e i c sr e v o f o n o i t a c i l b u p e h t n i

n i s r e p a p 0 0 0 1

i

y

a

eAwards21st ECCMID / 27th ICC / Milan Final Programme 2526 21st ECCMID / 27th ICC / Milan Final Programme Final Programme 1 Final ProgrammeI

i

c ISC Meritorious Membership is conferred upon persons who have extraordinarily contributed to, and supported, the aims of the ISC.The awardees in 2011, in conjunction with the 27th ICC, are:ISC Meritorious MembershipProfessor Victor LimProfessor Victor Lim served on the ISC Ex-ecutiveCommitteeinhiscapacityas PresidentoftheWesternPacicSociety of Chemotherapy.Professor Andrea NovelliProfessorAndreaNovellihasservedon theISCExecutiveCommitteeasboth FESCIPresidentandPresidentofthe 27th ICC / 21st ECCMID.Dr. David Livermore The award is for an outstanding research-er in the eld of infectious Diseases, Clini-cal Microbiology, and Antimicrobial Chem-otherapywhohasmadesignicant contributions to collaborative work in Tai-wan. This years winner is Dr. David Liver-more,DirectoroftheAntibioticResist-anceMonitoring&ReferenceLaboratory (ARMRL), HPA Centre for Infections, London.ISC Yen Award sponsored by theTaiwan Society of MicrobiologyThis award has been sponsored by the TaiwanSociety of Microbiology in memory of Professor Chi-Zhong Yen (1888 1974). In addition toProfessor Yens extensive experience in theprevention of infectious diseases and in medical education, he gathered together experts in theelds of medicine, agriculture, science and industry and founded the Chinese Society of Microbiology.Nishith MewadaThe recipient of the IASC award is Nishith Mewadawhowasbornin1986inMum-bai,India.Hecurrentlyworksasare-searchassistantattheDepartmentof Internal Medicine, Wayne State University, Michigan, US.Nishithandhisco-workerswill presentthefollowingworkduringthe congress:SignicanceofTroponin-Ival-ue in infective endocarditis.ISC Inter American Societyof Chemotherapy (IASC) Award

a

.

h

:

,

c in , 1 1 0 2 in s e e d war a e h Td e ut rib t n o c y aril din r o a r t x ership e mb e M s u o ri o t ri e M SC Is u o i r o t i r e M C S I

: are , C IC h 7t 2 e h t h t wi n o i t unc nj oe h t f o s aim e h t , d e t r o p p u s d an , o t da h o wh s n o rs e p n o p u d rre e nf o c is rshipp i h s r e b m e M

. SC Ie v a

a

y

. D I M C C E t s 1 2 / C C I h t 7 2e d i s e r P d n a t n e d i s e r P I C S E Fe e t t i m m o C e v i t u c e x E C S I e h ts a h i l l e v o N a e r d n A r o s s e f o r Pi l l e v o N a e r d n A r o s s e f o r P

e h t f o t n eh t o b s a en o d e v r e s

. y p a r e h t o m e h C f or e t s e W e h t f o t n e d i s e r Pn i e e t t i m m o C e v i t u c ev r e s m i L r o t c i V r o s s e f o r Pm i L r o t c i V r o s s e f o r P

y t e i c o S c i c a P n rs a y t i c a p a c s i h- x E C S I e h t n o d e v

o

t

d

.

e

f

y t e i c o S n a w i a TTas d r a w AAw n e YYe C S I

y g o l o i b o r c i M f oeh t y b d e r o s n o p

h t o m e h C f om A r e t n I C S I

dr a w AAw ) C S A I ( y p a r eyt e i c o S n a c i r e m

U

e

e

i

h

f R & i t i Mo i b i t n A e h t f o r o t c e r i D , e r o mD . r D s i r e n n i w s r a e y s i h T . n a ww e v i t a r o b a l l o c o t s n o i t u b i r t n o ce d a m s a h o h w y p a r e h t oo r c i m i t n A d n a , y g o l o i b o r c i M l a ce s i D s u o i t c e f n i f o d l e e h t n i r eg n i d n a t s t u o n a r o f s i d r a w a e h Ter o m r e v i L d i v a D . r D

t b L- t s i s e R c i t- r e v i L d i v a D- i a TTa n i k r o wt n a c i n g i s- m e h C l a i b o- i n i l C , s e s a- h c r a e s e r g

i l l f h t ts i h d n a h t i h s i N. S U , n a g i h c i Mn y a W , e n i c i d e M l a rn e t n Ie h t t a t n a t s i s s a h c r a e sy l t n e r r cu e H . a i d n I , i a brn o b s a w o h w a d a w e MSC A I e h t f o t n e i ip c re e h Ta d a w e M h t i h s i N

h t i d kl l i w s r e k r o w - o c, y t i s r e v i n U e t a t S ef o t n e m t r a p e D e- e r a s a s k r o w y- m u M n i 6 8 9 1 n ih t i h s i N is d war a SC

m

.

e

r

n

f medicine ds o elion, he gat at educion o t prevensor Y s e f o r Pg Y Chi-Zhonf M ociety o Sard h his aw T

o i t c e f n I r o f e r t n e C A P H , ) L R M R A (e c n e r e f e R & g n i r o t i n o M e c n ae and indus , scienc ure ult , agric f medicinehes in t t her exper oget hered t ion, he gats and in medic ase ious dise t ec f inffec ion ohee in t ve experienc ensi t s ex en YYenoion t t 4). In addi 7 9 1 8 8 8 en (1 YYen (1sors e ffe o r f P y in memory o iolog ob icr f Manw ai he T Tai as been sponsored by t ard h

. n o d n o L , s ny r o t a r o b a Lryt e and indushe als and in medicsor an

d r a c o d n e e v i t c e f n i n i e ue c n a c i n g i S : s s e r g n o cg n i w o l l o f e h t t n e s e r p

. s i t i d- l a v I - n i n o p o r T f oe h t g n i r u d k r o w

M

e

.

n

ounde and ffounded tf medicine ds o el

iolog ob icr f M ociety o se S he Chine ounded te and indus , scienc ure ult , agric f medicine

y. iologryt e and indus

a

eFinal Programme 1 Final ProgrammeISC Young Investigator Travel AwardsMagorzata Bodaszewska-LubasMagorzatawasbornin1981inKrosno, Poland. She is currently a PhD student at theJagiellonianUniversityMedicalCol-lege,CracowlookingatGroupBStrepto-cocciisolatedfrominvasiveinfections and carriers.Magorzataandherco-workerswill presenttheirworkduringthecongress entitled: Dependence of Group B Strepto-cocci adherence on serotypes and alpha-like protein genes.Ivan N. IvanovIvanwasbornin1978inSoa,Bulgaria. He gained his PhD in 2010 and currently works at the Reference Centre for Diagno-sis and Control of Nosocomial Infections, Soa, Bulgaria.Ivanandhisco-workerswillpresent theirworkduringthecongressentitled: Allele-specic-real-timePCRforcost- effectivecanonicalSNPgenotypingof Bacillus anthracis.Eirini ChristakiEiriniwasbornin1977inThessaloniki, Greeceandcombinespracticingmedi-cine with studying for a PhD at the Aristo-tleUniversityofThessalonikionthe pathophysiology of sepsis.Eiriniandherco-workerswillpresent thefollowingduringthecongress:Inter-alphainhibitorproteinsexhibitantiviral activity against inuenza strains in vitro.Olga LastovetskaOlgawasbornin1987inChernivtsky, Ukraine and is currently studying for her MasterofScienceDegreeinLaboratory Medicine and pathobiology at the Univer-sity of Toronto, Canada.Olgaandherco-workerswillpresent thefollowingworkduringthecongress: Surveillanceofextended-spectrumce-phalosporin-andcarbapenem resist-anceinEscherichiacolifromtheGreater Toronto Area, Ontario, Canada.Daniel AthanazioDaniel was born in 1977 in Salvador, Bra-zilandisaProfessorofPathologyinthe FederalUniversityofBahia,Salvador, Brazilwherehisresearchfocuseson leptospirosis.Daniel and his co-workers will present thefollowingworkduringthecongress: Experimentalleptospiralinfectionin transgenic / mutant mice: attenuated ne-phritisinindiciblenitricoxidesynthase (iNOS) knock-out C57BL/6 mice and pul-monaryhaemorrhagesinSCIDCB17and recombinaseactivatinggeneRag-1 knock-out C57BL/6 mice.James ElstonJameswasbornin1977inKingsLynn, UKandcurrentlyworksasaSpecialist RegistrarinHealthProtection / Public Health in North Yorkshire whilst studying for an MSc in Public Health.James and his co-workers will present the following during the congress: Pneu-mococcal vaccination and invasive pneu-mococcal disease in East Yorkshire, UK. Awards21st ECCMID / 27th ICC / Milan Final Programme 2728 21st ECCMID / 27th ICC / Milan Final Programme Final Programme 1 Final ProgrammeI ISC African Network GrantsSamuel M. KariukiSamwasborninKericho,Kenyaand works as a Chief Research Ofcer in Ken-ya Medical Research Institute. Forthelast15yearsSamhasbeen engagedinworkonsurveillanceand monitoringantimicrobialresistance amongkeyGramnegativepathogens, and also using various molecular tools to understandtheepidemiologyofantimi-crobial resistant infections.Marie-France PhobaMarie-France was born in Kinshasa, Dem-ocraticRepublicoftheCongo(RDC)and istrainingasaClinicalMicrobiologistat the University Hospital of Kinshasa. Marie-Franceisinvolvedinanetwork forthesurveillanceofbacteraemia,and thesurveillanceofantimicrobialresist-anceandwillshortlyembarkonastudy lookingatthemicrobiologicalaspectsof meningitis in RDC. Oladipo A. AboderinOladipowasborninIfewara,Nigeriaand practicesasaconsultantclinicalmicro-biologistattheObafemiAwolowoUniver-sityteachinghospitalscomplexanda seniorlecturerattheObafemiAwolowo University,bothinIle-Ife,southwestNi-geria.Oladipo is Principle Investigator in the projectAntibioticstewardshipatthe ObafemiAwolowoUniversityteaching hospitalscomplexandhasinitiatedthe measurementofantimicrobialuseand resistance in his hospital.Yilkal AsfawYilkal was born in Gojam, Ethiopia and is a veterinarianbyprofessionandiscur-rentlyDeanoftheFacultyofVeterinary Medicine, Addis Ababa University. Yilkalisinvolvedinresearchinvesti-gating the epidemiology and treatment of infectiousdiseasesinlivestockaswell asantimicrobialuseandresistancein livestock infectious diseases in Ethiopia.Final Programme 1 Final ProgrammeISC Masaaki Ohkoshi AwardCees van Nieuwkoop ThewinneroftheMasaakiOhkoshi Award 2011 is Cees van Nieuwkoop (Lei-den,NL)andhisgroupforthefollowing sevenpublicationsduring2009 2010 on febrile urinary tract infections:1. van Nieuwkoop C et al.BJU Int. 2010;105:1689 95.2. van Nieuwkoop C et al.BMC Infect Dis. 2009;9:131.3. van Nieuwkoop C et al.Clin Infect Dis. 2010;50:e69 72.4. van Nieuwkoop C et al. 2010;51:1266 72. 5. van Nieuwkoop C et al.Crit Care. 2010;14:R206.[Epub ahead of print]6. van Nieuwkoop C et al.J Infect 2010; 60:114 21. 7.van der Starre WE et al.Antimicrob Chemother.2010 Dec 1. [Epub ahead of print]ISC Tom Bergan and John David WilliamsMemorial AwardsProfessor Tom Bergan served the ISC as President (1997 2001), Secretary-General (1989 1997) and Executive Member (1985 1989). His signicant contributions included spearheading the establish-ment of the ofcial ISC journal. Professor John David Williams served the ISC as Associate Secretary (1977 1978), Secretary-General (1979 1989) and President (1989 1993). He wasthe rst Editor-in-Chief of the ISC journal, International Journal of Antimicrobial Chemotherapy. Funmilola Abidemi AyeniFunmilolawasborninNigeriaandwill presenttheabstract:Evaluationofthe potential of Weissella confusa and Lacto-bacillusparacaseiisolatedfromNigerian traditionaldairyfermentedfoodsand cows intestines.Devendra H. DusaneDevendrawasborninIndiaandwill presentthefollowingabstractonbehalf ofhisco-workers:Anovelglycolipidbio-surfactantfrommarineSerratiamarces-censdisruptspathogenicCandidaalbi-cansBHandPseudomonasaeruginosa PA01 biolms.Wichai SantimaleeworagunWichaiisfromThailandandwillpresent the following abstract on behalf of his co-workers:Molecularepidemiologyof Clostridiumdifcileandprevalenceof theNAP-1strainamongpatientsadmit-tedtoageneralandaprivatehospitalin Houston, Texas, US.The Masaaki Ohkoshi Award was founded in 1995 for the best clinical study on the subject of urinarytract infections published during a two-year period. The rst three awards were sponsored byProfessor Masaaki Ohkoshi and all subsequentawards have been sponsored by the JapaneseUTI Committee. These awards have been given at every ICC since 1995. Awards21st ECCMID / 27th ICC / Milan Final Programme 29Awards, Fellowships, Travel Grants 2011Travel Grant (500) and Free RegistrationThe ECCMID-ICC travel grant programme is sponsored by ESCMIDand ISC and were awarded to those with an outstanding abstract.Akinloye, Oluwabukola Margaret (Ogun State, NG)Ammerlaan, Heidi (Utrecht, NL)Berry, Lisa (London, UK)Blyth, Christopher (Perth, AU)Brjesson, Stefan (Uppsala, SE)Cottell, Jennifer (Birmingham, UK)Deeny, Sarah (London, UK)Desai, Darshana (London, UK)Diana, Michele (Lausanne, CH)Dominguez-Herrera, Juan (Seville, ES)Eustace, Andrew (Birmingham, UK)Faria, Nuno Alexandre (Oeiras, PT)Ferreira, Luis (Lisbon, PT)Gadsby, Naomi (Edinburgh, UK)Gan, Yuki (Hong Kong, HK)Grandgirard, Denis (Berne, CH)Hamprecht, Axel (Cologne, DE)Hensgens, Marjolein (Leiden, NL)Hofer, Sandra (Berne, CH)Hornsey, Michael (London, UK)Jensen, Rasmus Hare (Copenhagen, DK)Komp Lindgren, Patricia (Uppsala, SE)Lenz, Ryan (Calgary, CA)Luchs, Adriana (Sao Paulo, BR)Manzoor, Susan (Birmingham, UK)Mihailescu, Ioana Raluca (Bucharest, RO)Platteel, Tamara Nadine (Utrecht, NL)Quinteira, Sandra Maria (Vila Nova Famalicao, PT)Rolo, Joana (Oeiras, PT)Ruiz del Castillo, Beln (Santander, ES)Ruiz-Garbajosa, Patricia (Madrid, ES)Santos, Ana Catarina (Lisbon, PT)Sherry, Leighann (Glasgow, UK)Smani, Younes (Seville, ES)Snelders, Eveline (Nijmegen, NL)Stevens, Vanessa (Buffalo, US)Szabados, Florian (Bochum, DE)Tedim, Ana P. (Madrid, ES)van Mansfeld, Rosa (Utrecht, NL)Van Meensel, Britt (Aarschot, BE)Vlek, Anneloes (Utrecht, NL)Yu Mi, Wi (Changwon-si, KR)Zander, Esther (Cologne, DE)Zapasnik, Anna (Warsaw, PL)Free RegistrationFreeregistrationsaresponsoredbyESCMIDandISCandwere conditional upon acceptance of a high-quality abstract.Afanasev, Maxim (Irkutsk, RU)Amri, Manel (Algiers, DZ)Baietto, Lorena (Turin, IT)Barbier, Mariette (Palma de Mallorca, ES)Barchitta, Martina (Catania, IT)Baugh, Stephanie (Birmingham, UK)Beato, Slvia (Lisbon, PT)Biernat, Monika Maria (Wroclaw, PL)Campoli, Paolo (Montreal, CA)Cartman, Stephen (Nottingham, UK)Cataldo, Maria Adriana (Rome, IT)Chang, Fang Yu (Kuei Shan Hsiang, TW)El Chakhtoura, Nadim (Beirut, LB)Evans, Jason (Birmingham, UK)Ferguson, Patricia (Blacktown, AU)Fomichev, Mikhail (Tallinn, EE)Freitas, Francisco (Viseu, PT)Gazin, Muriel (Wilrijk, BE)Gharsa, Haythem (Logroo, ES)Giannella, Maddalena (Madrid, ES)Giomerzis, Nikolaos (Patras, GR)Gogou, Vasiliki (Volos, GR)Goldenberg, Simon (London, UK)Gmez-Sanz, Elena (Logroo, ES)Green, Laura (Wellington, NZ)Guglielmetti, Lorenzo (Verona, IT)Hiba, Vered (Holon, IL)Howard, Susan (Manchester, UK)Howard, Julia Catriona (London, UK)Ikonomidis, Alexandros (Larissa, GR)Ildiko, Pecsi (Budapest, HU)Islam, Mohammad Aminul (Dhaka, BD)Jain, Anu (London, UK)Jamrozy, Dorota (New Haw, UK)Joo, Eun-jeong (Seoul, KR)Kampschreur, Linda (Utrecht, NL)Kanji, Jamil (Edmonton, CA)Khanafer, Nagham (Lyon, FR)Kiratisin, Pattarachai (Bangkok, TH)Kirbs, Claudia (Halle, DE)Kochan, Piotr (Cracow, PL)Kontsevaya, Irina (Samara, RU)Kreder, Sabrina (Gieen, DE)Krizova, Lenka (Prague, CZ)Labrou, Maria (Giannouli, GR)Lopez Martinez, Maria (Logroo, ES)Lozano Fernandez, Carmen (Logroo, ES)Machado, Diana (Lisbon, PT)Manukian, Gregor (New Orleans, US)Martn-Pea, Almudena (Seville, ES)Mavridou, Eleftheria (Nijmegen, NL)Mendes, Elisa (Sao Paulo, BR)Mignone, Federica (Turin, IT)Miragaia, Maria (Oeiras, PT)Navarro-Laredo, Jose Luis (Madrid, ES)30 21st ECCMID / 27th ICC / Milan Final ProgrammeNielsen, Xiaohui Chen (Slagelse, DK)Novais, Carla (Sra. da Hora-Matosinhos, PT)Oostdijk, Evelien Ali Neeltje (Utrecht, NL)Persijn, Lies (Oostakker, BE)Pfeifer, Yvonne (Wernigerode, DE)Pinho, Marcos Daniel (Lisbon, PT)Pitart Ferre, Cristina (Barcelona, ES)Porres-Osante, Nerea (Logroo, ES)Rahal, Elias (Beirut, LB)Ramos, Andr (Lisbon, PT)Retamar Gentil, Pilar (Seville, ES)Ripoll Gonzalez, Aida (Madrid, ES)Rock, Clare (Dublin, IE)Rodrigues, Liliana (Lisbon, PT)Rottier, Wouter (Utrecht, NL)Rozemeijer, Wouter (Amsterdam, NL)Ruiz de Alegria Puig, Carlos (Santander, ES)Ruiz Ruiz, Elena (Logroo, ES)Saberi Kashani, Samaneh (Tehran, IR)Santos, Catia (Aveiro, PT)Seputiene, Vaida (Vilnius, LT)Shabir, Sahida (Birmingham, UK)Shan, Adriana (Madrid, ES)Sisco, Maria Carolina (Caracas, VE)Skjot-Rasmussen, Line (Copenhagen, DK)Somalo, Sergio (Logroo, ES)Teh, Benjamin (Heidelberg, AU)Teo, Jocelyn (Singapore, SG)Tome Francisco, Ana Patricia (Lisbon, PT)Trigo, Matilde (Pontevedra, ES)Troughton, Judith (Belfast, UK)van Mourik, Maaike S.M. (Utrecht, NL)van Zoelen, Marieke A.D. (Utrecht, NL)Varga, Zoltan Gabor (Szeged, HU)Vejpongsa, Pimprapa (Bangkok, TH)Vervoort, Jascha (Antwerp, BE)Vila-Farres, Xavier (Barcelona, ES)Voets, Guido Maarten (Utrecht, NL)Wilmer, Amanda (Vancouver, CA)Yeung, Man Kiu (Hong Kong, HK)Zakikhany, Katherina (London, UK)Zbinden, Andrea (Zurich, CH)Zhang, Lei (Chengdu, CN)Zong, Zhiyong (Chengdu, CN)Awards, Fellowships, Travel Grants 2011ESCMID ObservershipsImprove your clinical and laboratory skills!www.escmid.org /observershipsGet nancial support to visit our Collaborative Centresapplynow!Awards32 21st ECCMID / 27th ICC / Milan Final ProgrammeScientific Programme OverviewSaturday, 7 MayLecture Hall Gold Lecture Hall Red 1 Lecture Hall White 1 Lecture Hall White 2 Lecture Hall White 3 Lecture Hall Amber 107.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.00Sunday, 8 MayLecture Hall White 2 Lecture Hall White 3 Lecture Hall Amber 1 Lecture Hall Amber 2 Lecture Hall White 107.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.0019.0022.00Opening Ceremonyfollowed byWelcome ReceptionP. 27113.3015.30Surveillance of resistance in M. tuberculosis and potential impact of epide-miological cut-off valuesP. 4716.3018.30Infection control withoutbordersP. 50 16.3018.30Antimicrobial pharmacology: from bench to bedsideP. 5213.3015.30Clinical problems from parasitologyP. 4716.3018.30Emergence of virulent and antibiotic-resistant bacterialforms in the marine environ-ment: a public health concernP. 5113.3015.30Antimicrobial peptides update for infectiousdisease physiciansP. 4816.3018.30The role of PK/PD in the treatment of severeinfectionsP. 5113.1518.45TAETrainees DayinteractiveP. 4713.3015.30Molecular virologyP. 4816.3018.30New antimicrobial drugsin the pipelineP. 5208.4510.45EW06:Hand hygiene to controlHAI: what you still dontknowinteractiveP. 44 08.4510.45EW09:Emerging diagnostic methods in parasitologyP. 44 08.4513.00EW02:Fungi in the respiratory tract & antifungal stewardshipP. 43 08.4510.45EW05:Bacteraemia and sepsisinteractiveP. 44 08.45-10.45EW03:The epidemiology and clinical management of MRSA infectionP. 4311.0013.00EW13:Practical approaches toinfectioncontrol and treatmentof Clostridiumdifficile infectioninteractiveP. 45 11.0013.00EW16:Presentation of the ESCMIDdiagnostic & management guideline for Candida diseases 2011P. 46 11.0013.00EW14:New challenges in themanagement of viral hepatitis interactiveP. 46 11.0013.00EW15:Optimal management ofurinary tract infections(UTI) and prostatitisP. 46Lecture Hall Amber 209.0011.00Can we decrease hospital-acquired infectionsin "real" life?P. 5716.0018.00European preparedness and response to highly infectious diseasesP. 64 16.0018.00The role of PK/PD for choosing antifungal drugsP. 64 16.0018.00Diagnosis of bloodstream infections (BSI): present and futurebioMrieux16.0018.00Antibiotic combination interactionsP. 64 16.00 18.00Bad bugs need better drugs:addressing the global challengeAstraZenecaP. 6614.3015.30 P. 62ISC Hamao Umezawa AwardAntibiotic resistance: back to the bigger circle14.3015.30 P. 62The year in infection control14.3015.30 P. 62Are probiotics growth promoters in humans?14.3015.30 P. 63Molecular bacteriology: insight inthe virulence of Gram-positivecocci14.3015.30 P. 62Experience from humanitarian intervention in Haiti11.3012.30 P. 60Biofilm: from pathogenesis to preventive measures11.3012.30 P. 59Challenges in making a TB vaccine11.3012.30 P. 59Prospects for the control of neglected tropical diseases11.3012.30 P. 60Antifungal drugs make me mad:candins or azoles11.3012.30 P. 60Amoeba as genitor of new pathogenic microorganisms09.0011.00Genetics and epidemiologyof mobile resistance: mobilome & resistomeP. 56 09.0011.00New challenges for the infectious disease laboratorySiemensP. 59 09.0011.00What is changing in the invasive mycosis field?P. 5707.4508.45 P. 55Standardisation of molecular diagnostics in virology07.4508.45 P. 55EUCAST disk diffusion test frequently asked questions12.4514.15ESCMIDEuropean Council18.1519.30 P. 40ESCMID Assembly of Members09.0011.00The big question are we stay-ing ahead of antibiotic resi-stance in the hospital setting?Astellas Pharma EuropeP. 58P. 66Concert Sala Puccini at Conservatory of MilanProgramme Overview21st ECCMID / 27th ICC / Milan Final Programme 33Lecture Hall Amber 3 Lecture Hall Amber 4 Lecture Hall Silver Lecture Hall Brown 1 Lecture Hall Brown 2 Foyer & ExhibitionLecture Hall Brown 1 Lecture Hall Amber 4 Lecture Hall Amber 3 Lecture Hall Silver Lecture Hall Brown 2 Foyer & Exhibition07.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.0007.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.0013.3015.30Rare in the North, frequentin the South: infections from the MediterraneanBasinP. 4816.3018.30Spotlight on C. difficileinfections revealing the silent risk Astellas Pharma Europe/OptimerP. 5413.3015.30Hospital antibiotic use: causing or coping with multi-drug resistance?P. 4916.3018.30Bacterial invasive and non-invasive diseases: aetiology, epidemiology, treatment implications, prevention and surveillanceGSKP. 5413.3015.30New models for microbiology lab servicesP. 48 13.3015.30Emerging trends in the management of invasivefungal infections MSDP. 50 13.3015.30How to decrease resistance in the ICUP. 4816.3018.30ISF symposium and presentation of the International Sepsis Forum AwardP. 51 16.3018.30ESBLs from the environment to the clinicP. 53 16.3018.30New diagnostic methods for invasive fungal infectionsP. 5108.45-10.45EW07:Update in zoonotic infectionsP. 4411.0013.00EW17:Just when you thought it was safe to go back into the water: leisure-associated water-borneinfectionsP. 4608.45-10.45EW04:Infections in the immuno-compromised host an updateP. 4311.0013.00EW18:Regulation of efflux pumpsof bacteria by non-antibioticsP. 4708.45-10.45EW08:Resistance to anti-tuberculous drugs P. 4411.0013.00EW11:Molecular detection of antimicrobial resistanceP. 4508.45-10.45EW10:Rapid detection of resistanceP. 4511.0013.00EW12:Know your own local anti-biotic susceptibility datainteractiveP. 4516.0018.00Influenza H1N1 pandemicand complicationsP. 64 16.0018.00Mycobacterial disease to Epi and beyondP. 65 16.0018.00Bad bugs, which drugs? Superior potency for betteroutcomes in Gram-positiveinfectionsNovartisP. 66 16.0018.00The future of hospital antibiotic stewardship what should we achieve by 2020?P. 64 16.0018.00Pneumococcal disease in adults: a remaining challengePfizerP. 6614.3015.30 P. 63Genetics of NDM-114.3015.30 P. 62Metagenomics and detection of new viruses14.3015.30 P. 62ESCMID Excellence Award Vaccines, medicine and public health in the XXI century14.3015.30 P. 63Eradication of malaria14.3015.30 P. 63Antifungal management strategies11.3012.30 P. 61Antimicrobial activity of differentantibiotics or in combinationagainst MDR Gram-negative rods11.3012.30 P. 60Viral resistance testing where are we?11.3012.30 P. 60The year in infectious diseases11.3012.30 P. 60The disease and death of Enrico Caruso, Italian tenor11.3012.30 P. 60Pro vs Con:guideline vs clincialpractice-driven strategies in trea-ting severe infectious diseases09.0011.00New aspects of antimicrobialtreatment of anaerobic infectionsP. 56 09.0011.00Current and future perspective inclinical diagnosis of viral, bacterial,parasites and fungal pathogensusing a unique multiplexing technology LuminexP. 59 09.0011.00Q fever: a major threat in EuropeP. 56 09.0011.00Opportunistic infections in solid organ transplant recipientsP. 56 09.0011.00New updates on the management of MRSA nosocomial infectionPfizerP. 5907.4508.45 P. 55PK/PD for non-experts07.4508.45 P. 55Zoonoses for the non-initiated:when to suspect them, howtodiagnose them, howto treat them07.4508.45 P. 55Making research and reporting better usingthe ORION statement to design or evaluateinfection control intervention studies andoutbreak reports07.4508.45 P. 55MALDI-TOF identification (fungi, bacteria, viruses, cell cultures)Registration07.1518.15Exhibition10.0018.30Posters09.0018.00Poster Session I: 15.3016.30P. 32Poster Session II12.3013.30 Poster Session III13.3014.30Registration07.4519.00Exhibition12.0018.45Posters12.0019.00Poster Session I15.3016.30P. 50P. 61P. 62Symposia Meet-the-Expert Sessions and Educational WorkshopsKeynote and Special Lectures ESCMID and ISC MeetingsOral and Poster Sessions Social EventsIntegrated Symposia organized by the Industry TAE Trainees Day08.45-13.00EW01:Antimicrobial susceptibilitytestingP. 4334 21st ECCMID / 27th ICC / Milan Final ProgrammeScientific Programme OverviewMonday, 9 MayTuesday, 10 MayLecture Hall White 2 Lecture Hall White 3 Lecture Hall Amber 1 Lecture Hall Amber 2 Lecture Hall Amber 307.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.0009.0011.00Visceral leishmaniasis: an endemic disease withglobal impactGilead Sciences EuropeP. 7016.0018.00Impact of molecular diagnostics on public healthand patient careCepheidP. 81 16.00-18.00New insights in the role ofthe commensal floraP. 77 16.0018.00Embedding MALDI-TOF mass spectrometry in an open microbiology landscape BrukerP. 81 16.0018.00Virology (non-HIV / non-hepatitis)P. 78 16.0018.00Under your skin: skin manifestations of parasitic diseasesP. 7811.3012.30 P. 71150 years Semmelweis' publication on hand hygiene historical perspective14.3015.30 P. 76Infections and human geneticsusceptibility14.3015.30 P. 76Quality control: is it needed?14.3015.30 P. 76Man-made bacteria making new bacteria: possibilities, ethicalconsiderations, problems14.3015.30 P. 77Mycobacterium tuberculosis14.3015.30 P. 77Cellular and molecular immunology14.3015.30 P. 76Recent advances in the pathogenesisof Cytomegalovirus (CMV) andEpstein-Barr virus (EBV)11.3012.30 P. 74Epidemiology of antimicrobial resistance11.3012.30 P. 71Influenza: the reward year of the new H1N111.3012.30 P. 74Lyme borreliosis, toxoplasmosis09.0011.00Clinical and microbiologicalupdate on antibiotic-resistant P. aeruginosaP. 68 09.0011.00The efficient laboratory an ideal partner in clinicalpractice BD DiagnosticsP. 71 09.0011.00Tracking antibiotic resistance in Gram-positivecocciP. 69 09.0011.00Paediatrics infections: preclinical and clinical dataP. 6907.4508.45 P. 67Current issues on the detectionof carbapenem-resistant Gram-negative bacteria07.4508.45 P. 67Controversies in antiparasiticchemotherapy07.4508.45 P. 67Surgical site infections, how canwe prevent them, an evidencebased approach07.4508.45 P. 67Impossible-to-treat Gram-negative infectionsLecture Hall White 2 Lecture Hall White 3 Lecture Hall Amber 1 Lecture Hall Amber 2 Lecture Hall Amber 3 Lecture Hall White 107.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.0009.0011.00Bridging the gap of innova-tion - what we all could do09.0011.00Studying infectious diseases in vivoP. 83 P. 8413.3015.30Milestones in antimicrobialchemotherapy during thepast 50 years!P. 89 13.3015.30Controlling MRSA13.30-15.30Late presenters in EuropeP. 89 P. 8911.3012.30 P. 00Interventions in the use of antimicrobials11.3012.30 P. 87Enterococci where are we now?11.3012.30 P. 87RNAi and viral infections11.3012.30 P. 87ESCMIDYoung InvestigatorAward11.3012.30 P. 87Update on the new guidelines11.3012.30 P. 88Microbial pathogenesis, pathophysiology of infectionsdiseases11.3012.30 P. 88Acinetobacter baumannii: current situation09.0011.00Clinical Grand RoundsP. 83 09.0011.00Antifungals: in vitro and in vivo activity, pharma-cokinetics and resistanceP. 85 09.0011.00Tuberculosis: tests and diagnosisAbbottP. 87 09.0011.00Infectious disease with liverinvolvement - an updateP. 8307.4508.45 P. 82Infection prevention and diagnostics in critically ill patients in the ICU07.4508.45 P. 82Polymyxins: olds becomes newLecture Hall White 116. 0018.00Decisionpoints inthe managementof invasive Candida infections:Navigating the choices for optimalpatient careAstellas Pharma EuropeP. 8111.3012.30 P. 73MALDI-TOF:is it as good as we hoped?11.3012.30 P. 73CA-MRSA: what is going on with CA-MRSA?09.0011.00The growing challenges of multi-drug-resistant (MDR)Gram-negatives: what is yourstrategy now?JanssenP. 70Programme Overview21st ECCMID / 27th ICC / Milan Final Programme 3507.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.00Lecture Hall Brown 1 Lecture Hall Amber 4 Lecture Hall Silver Lecture Hall Brown 2 Foyer & Exhibition07.0008.0009.0010.0011.0012.0013.0014.0015.0016.0017.0018.0019.0020.0016.0018.00Pneumococcal infectionsand vaccineP. 79 16.0018.00Infection control methodsfor cancer patients undergoing treatmentP. 78 16.0018.00Infective endocarditis: lights and shadowsP. 78 16.00-18.00Management of complicatedinfections in the 21st century: current and futureapproachesPfizerP. 8114.30 15.30 P. 76Information technology and globalsurveillance of infectious diseases14.3015.30 P. 77New Delhi metallo-beta-lactamase(NDM) producers; the emergence ofMDR bacteria of global concern14.3015.30 P. 76Clinical management of urinarytract infections14.3015.30 P. 76Vancomycin and staphylococci is it as bad as the say?11.3012.30 P. 71Hospitalised CAP penicillin/doxy vs. FQ or Ceph3/macrolide?11.3012.30 P.73The year in clinical microbiology11.3012.30 P. 71New molecular diagnostics forparasitic diseases11.3012.30 P. 74HIV/AIDS09.0011.00Pathogenesis of ChlamydiainfectionsP. 68 09.0011.00Antimicrobial stewardshipworks why isn't it widelypracticed?P. 68 09.0011.00Next generation sequencingand clinical microbiologyP. 68 09.0011.00Update on the managementof fungal infections PfizerP. 7107.4508.45 P. 67Infection control for neutropeniccancer patients07.4508.45 P. 67Zygomycosis: an emerging fungal infectionRegistration07.3018.15Exhibition10.0018.30Posters09.0018.00Lecture Hall Brown 1 Lecture Hall Amber 4 Lecture Hall Silver Lecture Hall Brown 2 Foyer & Exhibition13.3015.30Imaging infectionP. 89 13.3015.30Resistant superbugs: a comparative analysis ofAsia versus EuropeP. 90 13.3015.30Risk factors other than neutropenia for developinginfection in immuno-suppressed patientsP. 9011.3012.30 P. 88Mycoplasma genitalium: the newChlamydia? From epidemiology to clinical diagnostics Bio-Rad09.0011.00Travel medicine: tropical and parasitic diseasesP. 85 09.0011.00C. difficile newsP. 86 09.0011.00Genetic predisposition and the outcome of infection: timeto include genetic polymor-phisms in routine diagnosticwork-up?P. 84 P. 7107.4508.45 P. 82Tropical mycoses: emergingIFIs inEurope ?07.4508.45 P. 82Vertical and horizontal infectioncontrol: pros and cons07.4508.45 P. 82Interferon-gamma releaseassays inTBdiagnosis07.4508.45 P. 82Laboratoryidentificationof beta-lactamases inGram-negativestrains withmultiple enzymes11.3012.30 P. 87Do youknowthe conceptof anti-anaerobic quinolones?11.3012.30 P. 87Invasive fungal infections in our hospitals todayRegistration07.3016.00Exhibition10.0013.30Posters09.0015.00Poster Session IV12.3013.30Poster Session V13.3014.3012.3014.30ISC Council MeetingRoom Yellow 318.0020.00ISC 50thAnniversary Foyer Lecture Hall Gold09.0011.00Antimicrobial-resistant bacteria in food and potablewater: a recipe for disaster?P. 83Symposia Meet-the-Expert Sessions and Educational WorkshopsKeynote and Special Lectures ESCMID and ISC MeetingsOral and Poster Sessions Social EventsIntegrated Symposia organized by the IndustryP. 39 P. 75P. 75Poster Session VI12.3013.30P. 89Inserat

21st ECCMID / 27th ICC / Milan Final Programme 37Introduction to the Scientific Programme CME Credits now onlineESCMID and ISC are seeking accreditation by the European Accredita-tion Council for Continuing Medical Education (EACCME) to provideCME credits for medical specialists. EACCME is an institution of theEuropeanUnionofMedicalSpecialists(UEMS,www.uems.net).EACCME credits are recognised as Physicians Recognition Awards by the American Medical Association. To claim CME credits log in onthecongresswebsite(www.eccmid-icc2011.org),linkCME.After completing the questionnaire, you can print the certificate indicatingthe CME credits.For the Italian CME accredition please refer to page 267.Educational WorkshopsAt the beginning of ECCMID / ICC on Saturday morning, 7 May 2011,from 08.4510.45, 08.4513.00 and 11.0013.00 several educa-tional workshops will take place. They are organised in cooperationwith ESCMID Study Groups, ISC Working Groups and other organi-sations.Participationintheeducationalworkshopsisfreeofcharge; however, delegates must register in advance as places arelimited.Ifyouarenotyetregisteredandwouldliketoattend,please go to the New Registration counters in the registrationarea onsite.Meet-the-Expert SessionsSundaythroughTuesday,thedaywillstartat07.45withupto six Meet-the-Expert Sessions led by experts in their field. Thesesessionscountonactiveparticipationoftheaudience.Afterashort presentation, the expert will open the session for discussion.Coffee will be offered.TAE Trainees DayOn Saturday, 7 May 2011, 13.1518.45, the Trainee Association of ESCMID (TAE) organises the first European Trainees Day, a dayof teaching dedicated to the unique needs of trainees. During thissession various topics in CM and ID will be discussed in a highlyinteractivewaybetweentraineesandexperi